These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1309798)
1. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798 [TBL] [Abstract][Full Text] [Related]
2. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. McLaughlin MM; Cieslinski LB; Burman M; Torphy TJ; Livi GP J Biol Chem; 1993 Mar; 268(9):6470-6. PubMed ID: 8384210 [TBL] [Abstract][Full Text] [Related]
3. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast. Wilson M; Sullivan M; Brown N; Houslay MD Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009 [TBL] [Abstract][Full Text] [Related]
4. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site. Barnette MS; Grous M; Cieslinski LB; Burman M; Christensen SB; Torphy TJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1396-402. PubMed ID: 7791113 [TBL] [Abstract][Full Text] [Related]
5. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding. Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. Torphy TJ; Zhou HL; Cieslinski LB J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058 [TBL] [Abstract][Full Text] [Related]
7. Biochemical characteristics and cellular regulation of phosphodiesterase IV. Torphy TJ; DeWolf WE; Green DW; Livi GP Agents Actions Suppl; 1993; 43():51-71. PubMed ID: 8396319 [TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities. Lugnier C; Gauthier C; Le Bec A; Soustre H Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036 [TBL] [Abstract][Full Text] [Related]
9. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase. Souness JE; Scott LC Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267 [TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of human type 4 phosphodiesterase isostates by (R, R)-(+/-)-methyl 3-acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate. Tian G; Rocque WJ; Wiseman JS; Thompson IZ; Holmes WD; Domanico PL; Stafford JA; Feldman PL; Luther MA Biochemistry; 1998 May; 37(19):6894-904. PubMed ID: 9578576 [TBL] [Abstract][Full Text] [Related]
11. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding. Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484 [TBL] [Abstract][Full Text] [Related]
12. CDP840: a novel inhibitor of PDE-4. Perry MJ; O'Connell J; Walker C; Crabbe T; Baldock D; Russell A; Lumb S; Huang Z; Howat D; Allen R; Merriman M; Walls J; Daniel T; Hughes B; Laliberte F; Higgs GA; Owens RJ Cell Biochem Biophys; 1998; 29(1-2):113-32. PubMed ID: 9631241 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium. Rousseau E; Gagnon J; Lugnier C Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488 [TBL] [Abstract][Full Text] [Related]
14. Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret. Duplantier AJ; Biggers MS; Chambers RJ; Cheng JB; Cooper K; Damon DB; Eggler JF; Kraus KG; Marfat A; Masamune H; Pillar JS; Shirley JT; Umland JP; Watson JW J Med Chem; 1996 Jan; 39(1):120-5. PubMed ID: 8568798 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE; Hassall GA; Parrott DP Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964 [TBL] [Abstract][Full Text] [Related]
16. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells. Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850 [TBL] [Abstract][Full Text] [Related]
17. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Souness JE; Diocee BK; Martin W; Moodie SA Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604 [TBL] [Abstract][Full Text] [Related]
18. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro. Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383 [TBL] [Abstract][Full Text] [Related]
19. Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities. Rocque WJ; Tian G; Wiseman JS; Holmes WD; Zajac-Thompson I; Willard DH; Patel IR; Wisely GB; Clay WC; Kadwell SH; Hoffman CR; Luther MA Biochemistry; 1997 Nov; 36(46):14250-61. PubMed ID: 9369498 [TBL] [Abstract][Full Text] [Related]
20. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors. Kelly JJ; Barnes PJ; Giembycz MA Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]